Literature DB >> 26718981

Genetic and Early Clinical Manifestations of Females Heterozygous for Duchenne/Becker Muscular Dystrophy.

Riccardo Papa1, Francesca Madia2, Domenico Bartolomeo1, Federica Trucco1, Marina Pedemonte1, Monica Traverso2, Paolo Broda1, Claudio Bruno3, Federico Zara2, Carlo Minetti4, Chiara Fiorillo5.   

Abstract

BACKGROUND: Female carriers of Duchenne muscular dystrophy (DMD), although usually asymptomatic, develop muscle weakness up to 17% of the time, and a third present cardiac abnormalities or cognitive impairment. Clinical features of DMD carriers during childhood are poorly known. PATIENTS: We describe a cohort of pediatric DMD carriers, providing clinical, genetic, and histopathologic features, with a mean follow-up of 7 years.
RESULTS: Fifteen females with a DMD mutation (age range 5 to 18 years) were included. Seven patients (46%) presented with clinically evident symptoms and signs such as limb girdle weakness, abnormal gait, and exercise intolerance. The other eight patients (53%) were evaluated because of an incidental finding of elevated level of creatine kinase. Creatine kinase level was elevated in all, ranging from 392 to 13,000 U/L. Calf hypertrophy was observed in eight patients (53%). No patient developed respiratory or cardiac involvement. The most frequent complication was scoliosis (46%). Four patients (29%) also presented minor learning disabilities or behavioral problems. We performed electromyography in half of patients, showing myopathic pattern in four (53%). Muscle biopsy revealed a mosaic reduction of dystrophin in nine available cases. DMD gene mutations were mostly deletions (71%), resulting in loss of reading frame in five patients (36%). The three patients who experienced the most severe disease course were affected either by a nonsense or frameshift mutation.
CONCLUSIONS: Our analysis suggests that DMD gene mutations may be suspected in a female child with persistently elevated levels of creatine kinase. Evidence of scoliosis, calf hypertrophy, or myopathic pattern at electromyography may also be helpful, and muscle biopsy is always indicative. DMD carriers should be followed for subtle orthopedic and psychiatric complications during childhood.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Duchenne muscular dystrophy; female carrier; pediatric

Mesh:

Substances:

Year:  2015        PMID: 26718981     DOI: 10.1016/j.pediatrneurol.2015.11.004

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  13 in total

1.  Muscular and cardiac manifestations in a Duchenne-carrier harboring a dystrophin deletion of exons 12-29.

Authors:  Josef Finsterer; Claudia Stöllberger; Birgit Freudenthaler; Desiree De Simoni; Romana Höftberger; Klaus Wagner
Journal:  Intractable Rare Dis Res       Date:  2018-05

2.  Differing disease phenotypes of Duchenne muscular dystrophy and Moyamoya disease in female siblings of a Korean family.

Authors:  Joonhong Park; Woori Jang; Ji Yoon Han
Journal:  Mol Genet Genomic Med       Date:  2019-07-25       Impact factor: 2.183

3.  Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patients.

Authors:  Binyamin Eisen; Ronen Ben Jehuda; Ashley J Cuttitta; Lucy N Mekies; Yuval Shemer; Polina Baskin; Irina Reiter; Lubna Willi; Dov Freimark; Mihaela Gherghiceanu; Lorenzo Monserrat; Michaela Scherr; Denise Hilfiker-Kleiner; Michael Arad; Daniel E Michele; Ofer Binah
Journal:  J Cell Mol Med       Date:  2019-01-08       Impact factor: 5.310

4.  In vivo cerebellar circuit function is disrupted in an mdx mouse model of Duchenne muscular dystrophy.

Authors:  Trace L Stay; Lauren N Miterko; Marife Arancillo; Tao Lin; Roy V Sillitoe
Journal:  Dis Model Mech       Date:  2019-12-09       Impact factor: 5.758

5.  Diagnosis of late-onset Pompe disease and other muscle disorders by next-generation sequencing.

Authors:  Sébastien Lévesque; Christiane Auray-Blais; Elaine Gravel; Michel Boutin; Laura Dempsey-Nunez; Pierre-Etienne Jacques; Sébastien Chenier; Sandrine Larue; Marie-France Rioux; Walla Al-Hertani; Amelie Nadeau; Jean Mathieu; Bruno Maranda; Valérie Désilets; Paula J Waters; Joan Keutzer; Stephanie Austin; Priya Kishnani
Journal:  Orphanet J Rare Dis       Date:  2016-01-25       Impact factor: 4.123

6.  Trendelenburg-Like Gait, Instability and Altered Step Patterns in a Mouse Model for Limb Girdle Muscular Dystrophy 2i.

Authors:  Joseph W Maricelli; Qi L Lu; David C Lin; Buel D Rodgers
Journal:  PLoS One       Date:  2016-09-14       Impact factor: 3.240

Review 7.  Cardiac Involvement in Dystrophin-Deficient Females: Current Understanding and Implications for the Treatment of Dystrophinopathies.

Authors:  Kenji Rowel Q Lim; Narin Sheri; Quynh Nguyen; Toshifumi Yokota
Journal:  Genes (Basel)       Date:  2020-07-08       Impact factor: 4.096

8.  Copy Number Variants Account for a Tiny Fraction of Undiagnosed Myopathic Patients.

Authors:  Teresa Giugliano; Marco Savarese; Arcomaria Garofalo; Esther Picillo; Chiara Fiorillo; Adele D'Amico; Lorenzo Maggi; Lucia Ruggiero; Liliana Vercelli; Francesca Magri; Fabiana Fattori; Annalaura Torella; Manuela Ergoli; Anna Rubegni; Marina Fanin; Olimpia Musumeci; Jan De Bleecker; Lorenzo Peverelli; Maurizio Moggio; Eugenio Mercuri; Antonio Toscano; Marina Mora; Lucio Santoro; Tiziana Mongini; Enrico Bertini; Claudio Bruno; Carlo Minetti; Giacomo Pietro Comi; Filippo Maria Santorelli; Corrado Angelini; Luisa Politano; Giulio Piluso; Vincenzo Nigro
Journal:  Genes (Basel)       Date:  2018-10-26       Impact factor: 4.096

9.  Connexin-43 reduction prevents muscle defects in a mouse model of manifesting Duchenne muscular dystrophy female carriers.

Authors:  Julie Nouet; Eric Himelman; Kevin C Lahey; Qingshi Zhao; Diego Fraidenraich
Journal:  Sci Rep       Date:  2020-03-30       Impact factor: 4.379

10.  Echocardiographic signs of subclinical cardiac function impairment in Duchenne dystrophy gene carriers.

Authors:  Vladimír Kincl; Roman Panovský; Martin Pešl; Jan Máchal; Lenka Juříková; Jana Haberlová; Lucia Masárová
Journal:  Sci Rep       Date:  2020-11-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.